Antibody-mediated rejection (AMR) is a form of transplant rejection where the recipient's immune system produces antibodies that specifically target and damage the donor organ, leading to graft dysfunction and potential loss. It is characterized by the presence of donor-specific antibodies, complement activation, and histological evidence of tissue injury in the transplanted organ.